**Title:** "Milestone Scientific Faces Revenue Decline: Navigating Challenges and Seizing Opportunities in a Competitive Landscape"

Performance of the Current Report

At December 31, 2024, Milestone Scientific (stock code: MLSS) had a total operating revenue of RMB2013514, which showed a significant year-on-year decrease compared to RMB2260596 at December 31, 2023.

Key Data in the Financial Report

1. The total operating revenue decreased by about 10.93% year-on-year, indicating that the company's revenue performance in 2024 was weaker than in 2023, which may affect its overall financial health.

2. Weak market demand may be one of the main reasons for the revenue decline.

3. Intensified industry competition may put pressure on the company's market share and pricing strategy.

4. Insufficient product innovation may also lead to customer loss and affect revenue.

5. Macroeconomic factors such as inflation or recession may affect consumer spending and, in turn, affect the company's sales revenue.

Peer Comparison

1. Industry-wide analysis: The overall medical equipment industry's revenue performance in 2024 may have been affected by the economic environment and changes in market demand, leading to a general decline in revenue. Further analysis of revenue changes in other companies within the industry is needed to understand the overall trend.

2. Peer evaluation analysis: Compared to the total operating revenue of other companies in the same industry, Milestone Scientific's revenue decline was more significant, indicating a weakening of its competitiveness in the market, and attention should be paid to changes in its relative position and market share in the industry.

Summary

Milestone Scientific's total operating revenue in 2024 saw a significant decrease, mainly affected by weak market demand, intensified competition, insufficient product innovation, and macroeconomic factors. The company needs to take effective market strategies and product innovation to address the challenges.

Opportunities

1. The company can enhance market demand and customer recognition by promoting its DPS dynamic pressure sensing technology.

2. Expanding the sales team and cooperating with global distributors can help increase market coverage.

3. After successfully obtaining FDA approval, the company can push its market strategy, which may lead to sales growth.

4. Strengthening market competitiveness through technological innovation and new product development.

Risks

1. Intensified competition may put greater pressure on the company's pricing and market share.

2. Failure to effectively launch new products or improve existing products may lead to further customer loss.

3. Macroeconomic uncertainties may continue to affect consumer spending and reduce sales revenue.

4. In the process of transformation, if the implementation is not effective, it may lead to resource waste and missed market opportunities.